New Clinical Data Lead to New Insights from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS), co-sponsored by Baxter, is designed to advance the understanding of optimal practices for peritoneal dialysis (PD) patients worldwide. At the American Society of Nephrology’s Kidney Week 2017, the PDOPPS will present two oral presentations with new clinical data contributing to the advancement of PD therapy.

Contemporary anemia management in peritoneal dialysis patients: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Abstract #TH-OR089)

A research team led by Dr. Rachel Perlman of the University of Michigan Health Center undertook the largest international study to date of anemia and iron management in PD patients. They found similar hemoglobin levels across countries, but significant differences in markers of iron adequacy and erythropoiesis stimulating agent use.

Notably, PD patients in the US have higher ferritin levels, iron saturation, and IV iron use than other countries. Future analyses will evaluate associations between anemia management practices and clinical and patient-reported outcomes.

Low serum potassium is associated with indicators of under-nutrition and reduced residual kidney function: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Abstract #TH-OR096)

We know that low serum potassium is associated with increased mortality risk in PD patients, but what else can serum potassium levels tell us? Dr. Simon J. Davies of University Hospital of North Midlands in the United Kingdom and other researchers found that low serum potassium levels, even within the normal range, may reflect under-nutrition. This is particularly true for patients with reduced residual kidney function.

Both presentations will take place on Thursday, November 2, from 4:30 to 6:30 p.m. in Room 290 of the Morial Convention Center.